Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized open-label trial of local compound aluminum sulfate injection versus TURBT for bladder tumors
CTR20171604Phase 3Active
- Sponsor
- Chinese PLA General Hospital
- Start
- Dec 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aluminum sulfate in non-muscle-invasive bladder cancer (NMIBC), benign bladder neoplasm, sponsored by Chinese PLA General Hospital. Started Dec 2017; status: active.
02
Drugs
aluminum sulfate
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)benign bladder neoplasm
Beyond the preview
Go deeper on CTR20171604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171604.